The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews. [PDF]
Correa da Costa S +7 more
europepmc +1 more source
[Efficacy of standard methods in the treatment of prolactin-secreting pituitary carcinoma]. [PDF]
Astafyeva LI +4 more
europepmc +1 more source
Cabergoline monotherapy in polycystic ovary syndrome patients with elevated prolactin: a viable option? [PDF]
Sıgınır A +4 more
europepmc +1 more source
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited. [PDF]
Glatfelter GC +4 more
europepmc +1 more source
8β-Carbobenzyloxyaminomethyl-1,6-dimethyl-10α-ergoline
C Beretta +3 more
openaire +1 more source
Serotonin 5-HT<sub>2C</sub> Receptor Signaling Analysis Reveals Psychedelic Biased Agonism. [PDF]
Bonniwell EM +9 more
europepmc +1 more source
Making Sense of Psychedelics in the CNS. [PDF]
Fordyce BA, Roth BL.
europepmc +1 more source
Budget impact analysis of cabergoline for medical treatment of Cushing's disease in Brazil. [PDF]
Silva LFO +3 more
europepmc +1 more source
Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice. [PDF]
Takaba R +12 more
europepmc +1 more source
Psychedelics: preclinical insights provide directions for future research. [PDF]
Gumpper RH, Roth BL.
europepmc +1 more source

